abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | NPORT-P: Others
abrdn Life Sciences Investors | DEFA14A: Others
abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Saba Capital Management, L.P.(11.29%),Boaz R. Weinstein(11.29%), etc.
abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | DEF 14A: Definitive information statements
abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | 3: Initial statement of beneficial ownership of securities-10% Owner Saba Capital Management, L.P.
abrdn Life Sciences Investors | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Saba Capital Management, L.P.(9.75%),Boaz R. Weinstein(9.75%), etc.
abrdn Life Sciences Investors | 4: Statement of changes in beneficial ownership of securities-Director Goetz Kathleen
abrdn Life Sciences Investors | 3: Initial statement of beneficial ownership of securities-Officer Tse Loretta
No Data